ZA200407794B - Novel biomaterials, their preparation and use. - Google Patents
Novel biomaterials, their preparation and use.Info
- Publication number
- ZA200407794B ZA200407794B ZA200407794A ZA200407794A ZA200407794B ZA 200407794 B ZA200407794 B ZA 200407794B ZA 200407794 A ZA200407794 A ZA 200407794A ZA 200407794 A ZA200407794 A ZA 200407794A ZA 200407794 B ZA200407794 B ZA 200407794B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- novel biomaterials
- biomaterials
- novel
- Prior art date
Links
- 239000012620 biological material Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02008809 | 2002-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200407794B true ZA200407794B (en) | 2006-02-22 |
Family
ID=29225593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200407794A ZA200407794B (en) | 2002-04-19 | 2004-09-28 | Novel biomaterials, their preparation and use. |
Country Status (20)
Country | Link |
---|---|
US (3) | US20050163853A1 (no) |
EP (1) | EP1499361B1 (no) |
JP (1) | JP4648632B2 (no) |
KR (1) | KR101121675B1 (no) |
CN (1) | CN1646171B (no) |
AU (1) | AU2003224099B2 (no) |
BR (1) | BR0309340A (no) |
CA (1) | CA2484100C (no) |
CO (1) | CO5611168A2 (no) |
ES (1) | ES2392964T3 (no) |
HK (1) | HK1073070A1 (no) |
IL (1) | IL164627A (no) |
MX (1) | MXPA04010325A (no) |
NO (1) | NO20044979L (no) |
NZ (1) | NZ535810A (no) |
PL (1) | PL215579B1 (no) |
PT (1) | PT1499361E (no) |
RU (1) | RU2321597C2 (no) |
WO (1) | WO2003089008A1 (no) |
ZA (1) | ZA200407794B (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
EP1706095B1 (en) | 2004-01-20 | 2008-12-24 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
WO2006011044A1 (en) * | 2004-07-22 | 2006-02-02 | Pfizer Products Inc. | Amorphous cyclodextrin compositions |
US8246949B2 (en) * | 2004-10-27 | 2012-08-21 | Aciont, Inc. | Methods and devices for sustained in-vivo release of an active agent |
EP1787658B1 (en) | 2005-11-10 | 2012-03-14 | CHEMI S.p.A. | Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
US8137512B2 (en) * | 2006-09-04 | 2012-03-20 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
JP2009186445A (ja) * | 2008-02-08 | 2009-08-20 | Arkray Inc | キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬 |
US9121821B2 (en) * | 2006-09-04 | 2015-09-01 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
US20100155242A1 (en) * | 2006-09-04 | 2010-06-24 | Arkray, Inc. | Method of Analyzing a Sample by Capillary Electrophoresis |
EP2400987B1 (en) * | 2009-02-25 | 2014-09-03 | Supratek Pharma, Inc. | Bendamustine cyclopolysaccharide compositions |
US20110015245A1 (en) * | 2009-07-20 | 2011-01-20 | Valery Alakhov | Bendamustine amphiphilic cationic compositions |
US8389558B2 (en) * | 2009-07-20 | 2013-03-05 | Supratek Pharma Inc. | Bendamustine amphiphilic anionic compositions |
ES2533030T3 (es) | 2010-03-13 | 2015-04-07 | Eastpond Laboratories Limited | Composiciones que enlazan grasa |
US8383663B2 (en) | 2010-07-19 | 2013-02-26 | Supratek Pharma Inc. | Bendamustine anionic-catioinic cyclopolysaccharide compositions |
EP4043037A1 (en) | 2010-12-31 | 2022-08-17 | Eastpond Laboratories Limited | Cellular hydration compositions containing cyclodextrins |
US20120171184A1 (en) | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
EP2672828B1 (en) | 2011-02-10 | 2015-04-29 | Unilever N.V. | Antimicrobial composition |
MX356582B (es) | 2012-01-18 | 2018-06-05 | Surmodics Inc | Recubrimiento para dispositivo medico lubrico con bajo nivel de material particulado. |
CA2932532C (en) * | 2012-12-04 | 2021-06-22 | Phosphorex, Inc. | Microparticles and nanoparticles having negative surface charges |
CN105392480A (zh) * | 2013-05-17 | 2016-03-09 | 马凯特大学 | 由离子液体组合物形成的含结构性多糖和大环化合物的复合材料 |
JP5673756B2 (ja) * | 2013-08-20 | 2015-02-18 | 東洋紡株式会社 | 医療用材料 |
RU2597085C2 (ru) * | 2013-11-07 | 2016-09-10 | Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) | Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты) |
EP3313364B1 (en) | 2015-06-24 | 2019-10-23 | Kao Germany GmbH | Hair treatment process |
US11174447B2 (en) | 2015-12-29 | 2021-11-16 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US10342898B2 (en) * | 2015-12-29 | 2019-07-09 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
WO2018075614A1 (en) | 2016-10-18 | 2018-04-26 | Marquette University | Composite materials containing structural polymers and photoreactive nitric odide releasing agents and uses thereof for wound dressings |
EP4132294A1 (en) | 2020-04-06 | 2023-02-15 | Eastpond Laboratories Limited | Compositions for promoting cellular hydration |
CN114344557A (zh) * | 2022-01-10 | 2022-04-15 | 山东万容生物科技有限公司 | 一种含环糊精的水胶体敷料及其制备方法 |
WO2023212740A1 (en) * | 2022-04-29 | 2023-11-02 | Drexel University | Surfactant-impregnated mof-coated fabric for antimicrobial applications |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE670837A (no) * | 1964-10-14 | 1966-01-31 | ||
JPS61251616A (ja) * | 1985-04-30 | 1986-11-08 | Agency Of Ind Science & Technol | 溶質の放出量の制御方法 |
JPS6416728A (en) * | 1987-07-07 | 1989-01-20 | Santen Pharmaceutical Co Ltd | Aqueous preparation |
JPH03234770A (ja) * | 1990-02-09 | 1991-10-18 | Nippon Shokubai Kagaku Kogyo Co Ltd | 電気刺激応答性ゲルの製法 |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
SE9303627D0 (sv) * | 1993-11-03 | 1993-11-03 | Kabi Pharmacia Ab | Method and means for prevention of cataract |
JPH08134134A (ja) * | 1994-11-09 | 1996-05-28 | Nippon Shokubai Co Ltd | 粒子状含水ゲル重合体の乾燥方法 |
JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
JPH0995413A (ja) * | 1995-09-29 | 1997-04-08 | Shiseido Co Ltd | 皮膚外用剤 |
GB9718568D0 (en) * | 1997-09-03 | 1997-11-05 | Chauvin Pharmaceuticals Limite | Compositions |
WO2000004916A1 (en) * | 1998-07-23 | 2000-02-03 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Encapsulation of water soluble peptides |
AU2608800A (en) * | 1999-01-12 | 2000-08-01 | Vito-Mannan Polysaccharide L.L.C. | Method of isolating mucilaginous polysaccharides and uses thereof |
JP2001318350A (ja) * | 2000-05-11 | 2001-11-16 | Lion Corp | コンタクトレンズ用溶液 |
MXPA02011254A (es) * | 2000-05-15 | 2003-03-10 | Procter & Gamble | Composiciones que comprenden ciclodextrina. |
US20020147232A1 (en) * | 2000-05-26 | 2002-10-10 | Claus Sundgreen | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
AU2002213429A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
-
2003
- 2003-04-17 KR KR1020047016698A patent/KR101121675B1/ko not_active IP Right Cessation
- 2003-04-17 CN CN038088592A patent/CN1646171B/zh not_active Expired - Fee Related
- 2003-04-17 JP JP2003585759A patent/JP4648632B2/ja not_active Expired - Fee Related
- 2003-04-17 BR BR0309340-9A patent/BR0309340A/pt not_active IP Right Cessation
- 2003-04-17 ES ES03720497T patent/ES2392964T3/es not_active Expired - Lifetime
- 2003-04-17 RU RU2004133887/04A patent/RU2321597C2/ru not_active IP Right Cessation
- 2003-04-17 US US10/511,075 patent/US20050163853A1/en not_active Abandoned
- 2003-04-17 MX MXPA04010325A patent/MXPA04010325A/es active IP Right Grant
- 2003-04-17 PT PT03720497T patent/PT1499361E/pt unknown
- 2003-04-17 PL PL371595A patent/PL215579B1/pl unknown
- 2003-04-17 EP EP03720497A patent/EP1499361B1/en not_active Expired - Lifetime
- 2003-04-17 WO PCT/EP2003/004076 patent/WO2003089008A1/en active Application Filing
- 2003-04-17 NZ NZ535810A patent/NZ535810A/en not_active IP Right Cessation
- 2003-04-17 AU AU2003224099A patent/AU2003224099B2/en not_active Ceased
- 2003-04-17 CA CA2484100A patent/CA2484100C/en not_active Expired - Fee Related
-
2004
- 2004-09-28 ZA ZA200407794A patent/ZA200407794B/xx unknown
- 2004-10-14 IL IL164627A patent/IL164627A/en not_active IP Right Cessation
- 2004-10-26 CO CO04107397A patent/CO5611168A2/es active IP Right Grant
- 2004-11-16 NO NO20044979A patent/NO20044979L/no not_active Application Discontinuation
-
2005
- 2005-07-07 HK HK05105740.7A patent/HK1073070A1/xx unknown
-
2008
- 2008-07-24 US US12/178,934 patent/US20080299166A1/en not_active Abandoned
-
2011
- 2011-10-25 US US13/281,033 patent/US20120040901A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL164627A (en) | 2009-11-18 |
KR101121675B1 (ko) | 2012-03-13 |
IL164627A0 (en) | 2005-12-18 |
RU2004133887A (ru) | 2005-10-20 |
PT1499361E (pt) | 2012-11-22 |
NZ535810A (en) | 2007-11-30 |
WO2003089008A1 (en) | 2003-10-30 |
AU2003224099B2 (en) | 2006-11-09 |
CN1646171A (zh) | 2005-07-27 |
JP2005529879A (ja) | 2005-10-06 |
US20050163853A1 (en) | 2005-07-28 |
EP1499361B1 (en) | 2012-08-08 |
BR0309340A (pt) | 2005-03-08 |
AU2003224099A1 (en) | 2003-11-03 |
RU2321597C2 (ru) | 2008-04-10 |
US20080299166A1 (en) | 2008-12-04 |
NO20044979L (no) | 2004-11-16 |
CA2484100A1 (en) | 2003-10-30 |
HK1073070A1 (en) | 2005-09-23 |
CN1646171B (zh) | 2010-05-26 |
CA2484100C (en) | 2012-01-03 |
PL371595A1 (en) | 2005-06-27 |
KR20040103968A (ko) | 2004-12-09 |
PL215579B1 (pl) | 2013-12-31 |
ES2392964T3 (es) | 2012-12-17 |
JP4648632B2 (ja) | 2011-03-09 |
US20120040901A1 (en) | 2012-02-16 |
MXPA04010325A (es) | 2005-06-08 |
EP1499361A1 (en) | 2005-01-26 |
CO5611168A2 (es) | 2006-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200407794B (en) | Novel biomaterials, their preparation and use. | |
TWI371450B (en) | Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use | |
EG25011A (en) | Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments. | |
ZA200201806B (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof. | |
MX248882B (es) | Composiciones, polimeros y metodos para fijacion del cabello. | |
ZA200103580B (en) | Aluminosilicate compositions, preparation and use. | |
EP1617807A4 (en) | SUBSTITUTED 1,4-DIAZEPINE AND ITS USES | |
ZA200501431B (en) | 5-Aryltetrazole compounds, compositions thereof, and uses therefor. | |
HK1081954A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
MXPA03009167A (es) | PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA. | |
MXPA03008771A (es) | Masa, productos y metodos. | |
AU2003217565A8 (en) | Polydioxaborines, their monomers and their preparation | |
TWI348382B (en) | N-acetylglucosamine derivatives, and the use thereof | |
ZA200002546B (en) | Sorbate-preserved compositions, method for the manufacture thereof and their use. | |
EP1517879A4 (en) | AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE | |
GB0217548D0 (en) | Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12 | |
GB0305089D0 (en) | Composition, use and process | |
ZA200109571B (en) | Novel compounds, their use and preparation. | |
AU2003299336A8 (en) | Diphosphines, preparation and uses thereof | |
EP1660088A4 (en) | PYRIDOMORPHINANES, PYRIDAZINOMORPHINANES AND USE THEREOF | |
MXPA03007550A (es) | Derivados coloporosidos, proceso para su preparacion y su uso. | |
MXPA02005784A (es) | Cepillo de dientes, estruche-mango para el mismo y soporte para dicho cepillo de dientes. | |
GB0229445D0 (en) | Process,composition and use | |
GB0326138D0 (en) | Polymers, their preparation and uses | |
GB2420345B (en) | 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use |